Daptomycin
DAPZURA RT
Lipopeptide Antibacterial
NADAC/unit
$13.4180
No Shortage
Tier 1: 32.2%
16 Manufacturers
21 ANDAs
Daptomycin for injection is a lipopeptide antibacterial indicated for the treatment of: • Complicated skin and skin structure infections (cSSSI) in adult and pediatric patients (1 to 17 years of ag....
vs. brand DAPZURA RT: Generic saves up to -34% per unit
Market Intelligence
2023-03-08 Class II Recall: Accord Healthcare, Inc.
2023-03-08 Class II Recall: Accord Healthcare, Inc.
Generic Manufacturers
ACCORD HEALTHCARE INCASPIRO PHARMA LTDBAXTER HEALTHCARE CORPBE PHARMACEUTICALS AGBIOCON PHARMA LTDDR REDDYS LABORATORIES LTDEUGIA PHARMA SPECIALITIES LTDFRESENIUS KABI USA LLCHAINAN POLY PHARMACEUTICAL CO LTDHIKMA PHARMACEUTICALS USA INCHISUN PHARMACEUTICAL HANGZHOU CO LTDHOSPIRA INCMAIA PHARMACEUTICALS INCMEITHEAL PHARMACEUTICALS INCMYLAN LABORATORIES LTDMYLAN PHARMACEUTICALS INC A VIATRIS COQILU PHARMACEUTICAL HAINAN CO LTDSAGENT PHARMACEUTICALS INCTEVA PHARMACEUTICALS USA INCXELLIA PHARMACEUTICALS APS
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.